Aspiriant LLC’s Vanguard Dividend Appreciation ETF VIG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $205M | Buy |
955,149
+1,122
| +0.1% | +$250K | 5.85% | 6 |
|
|
2025
Q4 | $210M | Sell |
954,027
-14,506
| -1% | -$3.17M | 6.02% | 6 |
|
|
2025
Q3 | $209M | Buy |
968,533
+4,469
| +0.5% | +$938K | 6.39% | 5 |
|
|
2025
Q2 | $197M | Buy |
964,064
+9,151
| +1% | +$1.77M | 6.27% | 6 |
|
|
2025
Q1 | $185M | Buy |
954,913
+3,483
| +0.4% | +$693K | 6.43% | 6 |
|
|
2024
Q4 | $186M | Sell |
951,430
-17,352
| -2% | -$3.46M | 6.73% | 6 |
|
|
2024
Q3 | $192M | Buy |
968,782
+66
| +0% | +$12.6K | 7.28% | 5 |
|
|
2024
Q2 | $177M | Buy |
968,716
+6,312
| +0.7% | +$1.14M | 7.21% | 5 |
|
|
2024
Q1 | $176M | Sell |
962,404
-10,604
| -1% | -$1.86M | 7.27% | 5 |
|
|
2023
Q4 | $166M | Buy |
973,008
+22,956
| +2% | +$3.69M | 7.47% | 4 |
|
|
2023
Q3 | $148M | Sell |
950,052
-1,050
| -0.1% | -$170K | 7.55% | 4 |
|
|
2023
Q2 | $154M | Sell |
951,102
-4,781
| -0.5% | -$749K | 7.81% | 4 |
|
|
2023
Q1 | $147M | Sell |
955,883
-27,774
| -3% | -$4.25M | 7.71% | 4 |
|
|
2022
Q4 | $149M | Sell |
983,657
-354,606
| -26% | -$52.9M | 7.61% | 4 |
|
|
2022
Q3 | $181M | Buy |
1,338,263
+285,220
| +27% | +$42.4M | 8.85% | 3 |
|
|
2022
Q2 | $151M | Buy |
1,053,043
+314,029
| +42% | +$47.8M | 7.29% | 4 |
|
|
2022
Q1 | $120M | Buy |
739,014
+32,519
| +5% | +$5.25M | 6.59% | 4 |
|
|
2021
Q4 | $121M | Buy |
706,495
+29,786
| +4% | +$4.91M | 6.49% | 4 |
|
|
2021
Q3 | $104M | Buy |
676,709
+34,392
| +5% | +$5.48M | 6.1% | 4 |
|
|
2021
Q2 | $99.4M | Buy |
642,317
+54,846
| +9% | +$8.42M | 5.62% | 4 |
|
|
2021
Q1 | $86.4M | Sell |
587,471
-6,126
| -1% | -$871K | 5.52% | 4 |
|
|
2020
Q4 | $83.8M | Buy |
593,597
+30,187
| +5% | +$4.09M | 5.72% | 4 |
|
|
2020
Q3 | $72.5M | Buy |
563,410
+63,975
| +13% | +$8.05M | 5.67% | 3 |
|
|
2020
Q2 | $58.5M | Sell |
499,435
-8,362
| -2% | -$952K | 5.43% | 3 |
|
|
2020
Q1 | $52.5M | Buy |
507,797
+45,490
| +10% | +$5.43M | 5.17% | 5 |
|
|
2019
Q4 | $57.6M | Buy |
462,307
+10,302
| +2% | +$1.25M | 5.33% | 2 |
|
|
2019
Q3 | $54.1M | Buy |
452,005
+6,160
| +1% | +$727K | 4.84% | 2 |
|
|
2019
Q2 | $51.3M | Buy |
445,845
+11,043
| +3% | +$1.24M | 4.28% | 5 |
|
|
2019
Q1 | $47.7M | Buy |
434,802
+10,234
| +2% | +$1.08M | 3.89% | 5 |
|
|
2018
Q4 | $41.6M | Buy |
424,568
+17,612
| +4% | +$1.84M | 3.15% | 7 |
|
|
2018
Q3 | $45M | Sell |
406,956
-601
| -0.1% | -$64.6K | 3.85% | 4 |
|
|
2018
Q2 | $41.4M | Sell |
407,557
-12,245
| -3% | -$1.25M | 3.55% | 4 |
|
|
2018
Q1 | $42.4M | Buy |
419,802
+306,664
| +271% | +$31.8M | 3.7% | 4 |
|
|
2017
Q4 | $11.5M | Sell |
113,138
-317,283
| -74% | -$31.2M | 3.39% | 10 |
|
|
2017
Q3 | $40.8M | Sell |
430,421
-1,734
| -0.4% | -$162K | 3.42% | 5 |
|
|
2017
Q2 | $40M | Buy |
432,155
+98,720
| +30% | +$9.06M | 3.48% | 5 |
|
|
2017
Q1 | $30M | Buy |
333,435
+312,053
| +1,459% | +$27.7M | 2.55% | 10 |
|
|
2016
Q4 | $1.82M | Buy |
21,382
+2,385
| +13% | +$201K | 0.16% | 80 |
|
|
2016
Q3 | $1.59M | Buy |
18,997
+15,532
| +448% | +$1.32M | 0.16% | 80 |
|
|
2016
Q2 | $272K | Sell |
3,465
-4,920
| -59% | -$402K | 0.03% | 161 |
|
|
2016
Q1 | $682K | Buy |
+8,385
| New | +$643K | 0.07% | 117 |
|
Other funds holding VIG
VGA
HWM
Aspiriant LLC's VIG Position: Q1 2026 in Review
Aspiriant LLC increased its Vanguard Dividend Appreciation ETF (VIG) stake by 0.12% in Q1 2026, buying an estimated $250K and bringing the position to 955,149 shares worth $205M. The position accounts for 5.85% of the portfolio, ranked #6.
Aspiriant LLC first reported a position in VIG in Q1 2016 and has held it in 41 quarters since. The position peaked at $210M in Q4 2025. 2,512 funds tracked by Wall St. Rank hold VIG as of Q1 2026.
- Aspiriant LLC held 955,149 shares of Vanguard Dividend Appreciation ETF worth $205M as of Q1 2026.
- Aspiriant LLC bought 1,122 Vanguard Dividend Appreciation ETF shares in Q1 2026, an estimated $250K.
- Vanguard Dividend Appreciation ETF made up 5.85% of Aspiriant LLC's portfolio in Q1 2026, its #6 holding.
- Aspiriant LLC first reported a position in Vanguard Dividend Appreciation ETF in Q1 2016 and has held it in 41 quarters since.
- Aspiriant LLC's Vanguard Dividend Appreciation ETF position peaked at $210M in Q4 2025.
- 2,512 funds tracked by Wall St. Rank held Vanguard Dividend Appreciation ETF as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.